NBC Securities’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30K Buy
332
+257
+343% +$21.5K ﹤0.01% 1492
2026
Q1
$6.01K Hold
75
﹤0.01% 2064
2025
Q4
$6.39K Hold
75
﹤0.01% 2142
2025
Q3
$5.83K Hold
75
﹤0.01% 2156
2025
Q2
$5K Hold
75
﹤0.01% 2098
2025
Q1
$5K Buy
+75
New +$5.37K ﹤0.01% 1857
2024
Q4
Sell
-75
Closed -$4K 1509
2024
Q3
$4K Sell
75
-43
-36% -$3.12K ﹤0.01% 1922
2024
Q2
$10K Sell
118
-1
-0.8% -$89 ﹤0.01% 1681
2024
Q1
$11K Sell
119
-99
-45% -$8.32K ﹤0.01% 1664
2023
Q4
$16K Sell
218
-547
-72% -$38.1K ﹤0.01% 1552
2023
Q3
$52K Buy
+765
New +$61.5K 0.01% 1119

Other funds holding EW

NBC Securities's EW Position: Q2 2026 in Review

NBC Securities increased its Edwards Lifesciences (EW) stake by 343% in Q2 2026, buying an estimated $21.5K and bringing the position to 332 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

NBC Securities first reported a position in EW in Q3 2023 and has held it in 11 quarters since. The position peaked at $52K in Q3 2023. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • NBC Securities held 332 shares of Edwards Lifesciences worth $30K as of Q2 2026.
  • NBC Securities bought 257 Edwards Lifesciences shares in Q2 2026, an estimated $21.5K.
  • Edwards Lifesciences made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1492 holding.
  • NBC Securities first reported a position in Edwards Lifesciences in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Edwards Lifesciences position peaked at $52K in Q3 2023.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.